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Abstract
The significance of the epicardium that covers the heart and the roots of the great
arteries should not be underestimated as it is a major component with impact on
development, disease, and repair. The epicardium differentiates from the
proepicardial organ located at the venous pole (vPEO). The differentiation
capacities of the vPEO into epicardium-derived cells (EPDCs) have been exten-
sively described. A hitherto escaped part of the epicardium derives from a second
proepicardial organ located at the arterial pole (aPEO) and covers the intraper-
icardial part of the aorta and pulmonary trunk. In avian and mouse embryos,
disturbance of epicardium differentiation causes a spectrum of cardiac anomalies
including coronary artery abnormalities, deficient annulus fibrosis with rhythm
disturbances, valvemalformations, and non-compaction cardiomyopathies. Late in
prenatal life the epicardium becomes dormant, losing the activity of many genes.
In human cardiac diseases, both arterial and venous epicardium can be activated
again into EPDCs. The epicardial reactivation observed after experimental
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myocardial infarction and during aneurysm formation of the ascending aorta provides
clinical relevance. EPDCs applied for cell therapy demonstrate repair processes
synergistic with the resident cardiac progenitor stem cells that probably share an
embryonic origin with EPDCs. Future therapeutic strategies might be possible
addressing cell autonomous-based and signaling capacities of the adult epicardium.
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2.1 Origin of the Epicardium
The cardiogenic mesoderm is referred to as first heart field, flanked medially by second
heart field (SHF)mesoderm. The addition of SHF-derived cardiacmesoderm enables the
formation of all cardiac components. A secondary layer will cover the complete
myocardial tube (Fig. 2.1) and the developing roots of the great arteries. At the venous
pole, the vPEO develops fromwhich the epicardium (cEP) spreads over the cardiac tube
up to the ventriculo-arterial junction [1]. Here, the cEP meets the PEO located at the
arterial pole (Fig. 2.2) [2] forming arterial epicardium (aEP) that is continuous with the
pericardium.BothPEOstructures and the spreading cEPand aEPexpressWilms’ tumor-
1 suppressor gene (WT-1) among others and harbor endothelial and mesenchymal cells.
2.2 Epicardium-Derived Cells (EPDCs)
Epicardial cells lose epithelial contacts by epithelial–mesenchymal transition
(EMT) and EPDCs relocate subepicardially [3, 4]. Early EPDCs invade the thin
myocardial wall. Proliferation of the myocardium depends on both endocardial-
and epicardial-derived signals, including Raldh2 [5] with a spatiotemporal differ-
ence between right and left ventricle (Fig. 2.1). The aEP starts EMT slightly later
than cEP, and ensuing EPDCs can be detected in the outer layers of the developing
great arteries and at the myocardial–endocardial cushion interface (Fig. 2.2).
Epicardial heterogeneity with a subset of cells taking part in the initial EMT
wave provides the myocardium with the main number of the future interstitial
fibroblasts. The next wave of EMT correlates with the formation of the fibrous
atrioventricular annulus [6] and contributes to part of the atrioventricular cushion
cells. At the ventriculo-arterial junction aEP migrates into the outflow tract forming
the future arterial annuli and partake in the semilunar valves [7].
12 A.C. Gittenberger-de Groot et al.
2.3 Heterogeneity of Epicardial Cells
2.3.1 The Cardiac Fibroblast
The epicardium is the main source of the interstitial, the fibrous annulus, and the
coronary adventitial fibroblasts [7, 8]. The endocardial cells lining the cushions are







Fig. 2.1 Four-chamber view of a mouse heart (ED12.5) immunostained for WT1. Note brown
cells lining the pericardial cavity (PC), including the epicardium. The AV groove is indicated
(arrows). The left ventricular (LV) wall contains hardly EPDCs, whereas some are present in the
RV and in the interventricular septum (IVS). Note the presence of EPDCs at the border of the AV
cushion and the interatrial septum (short arrows)
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2.3.2 Arterial Smooth Muscle Cell
After ingrowth of the peritruncal coronary capillary plexus into the aorta, EPDCs
surround the main coronary vessels and differentiate into smooth muscle
cells (SMC). Differentiation into SMCs is regulated by many genes including
FGF, VEGF, Notch, SRF, and PDGFRb and their ligands [8]. Quail–chicken





Fig. 2.2 Cross section of aorta (Ao) and right ventricular outflow tract (R-OFT). Aortic epicar-
dium is densely packed and cuboid (arrows), whereas cEP is squamous (short arrows). Note
EPDCs at the border of R-OFT cushions and myocardium and between Ao and R-OFT
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2.3.3 Endothelial Cells
The origin of the coronary endothelium is still under debate. Using a quail vPEO
transplanted into the isochronous chick as reviewed in [10] pointed out that
coronary ECs do not derive from the coelomic lining but from endothelial cells
from the sinus venosus sprouting into the stalk of the vPEO. This is also supported
by studies using transgenic mice [11]. We have shown that the sinus venosus-
derived endothelial cells express the “arterial” Notch1, underlining the plasticity of
these cells [9]. The discussion on the origin of the coronary endothelium is kept
alive as specific compartments produce restricted numbers of ECs [12, 13].
2.3.4 Cardiomyocytes
Conditional reporter mice studies, using WT-1 and Tbx18 as epicardial marker,
suggested that a population of EPDCs might differentiate into a myocardial pheno-
type. However, based on interaction between BMP and FGF, some of the
progenitors of cardiomyocytes in the SHF share the same markers with cells in
the underlying mesoderm of the SHF and the epicardial population [14]. Other data,
including quail–chicken chimera, also do not support EPDC–cardiomyocyte
transition [3].
2.3.5 The Purkinje Fiber
The Purkinje fiber is a specialized cardiomyocyte induced by endothelin produced
by endocardium and endothelium. We have postulated an essential interaction
between EPDCs and endocardial-/endothelial-derived factors after vPEO tracing
and inhibition experiments [15].
2.4 Congenital and Adult Cardiac Disease
In a large-screen microarray [16], no epicardium-specific gene has been encoun-
tered. Therefore, it is challenging to attribute specific cardiac malformations and
diseases to epicardial malfunctioning. However, in animal models it is possible to
link the epicardium to certain cardiac defects and diseases. We are dealing with
complex tissues in which epicardial cells are essential.
2.4.1 Non-compaction
The most relevant cardiomyopathy resulting from abnormal EPDC function is the
primary left ventricular non-compaction cardiomyopathy [4] demonstrating a
spongious myocardium usually including the ventricular septum. Differences in
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amount and timing of LV and RV invasion by EPDCs might account for predilec-
tion of the LV. With respect to congenital heart disease, a spongious ventricular
septum can be connected with muscular VSDs.
2.4.2 Conduction System Anomalies
The main components of the conduction system are myocardial in origin. Clini-
cally, it has been hypothesized that the genetically determined long QT syndrome is
linked to abnormal Purkinje fiber function. Indirectly, the abnormal formation of
the fibrous annulus with persisting accessory pathways can result in reentry
tachycardias. PEO inhibition in chick embryos showed defective atrioventricular
isolation, delaying the shift from a base-to-apex to an apex-to-base conduction [17].
2.4.3 Valvulopathies
PEO inhibition can lead to deficient AV valve formation [18, 19]. Furthermore,
abnormal differentiation including defective undermining of the valve leaflet is
similar to Ebstein’s anomaly of the tricuspid valve as observed in combination with
accessory pathways [4]. EPDCs of aEP origin are found in the outflow tract
cushions (Fig. 2.2) probably acting via Notch signaling and hence influencing
bicuspid aortic valve formation.
2.4.4 Coronary Vascular Anomalies
Experimental studies disturbing normal coronary development result in a number of
malformations that associate human congenital pattern variations with abnormal
ventriculo-coronary-arterial communications (fistulae). Fistulae found in avian
models with absent coronary arterial orifices in the aorta [20] resembling coronary
malformations found in pulmonary atresia without VSD are hypothesized to be a
primary coronary vascular disease [21].
2.5 Cardiovascular Repair
Myocardial infarction. Different approaches have focused on the potential of the
adult epicardial cell after myocardial infarction (MI). A c-kit-positive subepicardial
population indicates renewed epicardial activity with acquisition of stem cell
characteristics [22]. Using a retrovirally induced fluorescent Katushka labeling of
dormant epicardium showed EPDCs that migrated into the myocardium and
differentiated into a myofibroblast phenotype. The activated epicardium and
EPDCs reexpressed WT1 not only in the MI border zone but also in remote areas.
Another approach is represented by epicardial cells cocultured with
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cardiomyocytes in which EPDCs change myocardial alignment and contraction
[23]. A direct approach was provided by grafting human adult atrial epicardial cells
[24] cultured in vitro from a cobblestone epithelium into spindle shape, thereby
acquiring characteristics of mesenchymal stem cells. Injection of these adult human
EPDCs into immune-incompetent mice resulted in a marked improvement of
cardiac function [24] indicative of repair. Combined injection with adult human
cardiomyocyte progenitors (CMPCs) aimed at induction of cardiomyocyte regen-
eration [25] which showed an additive effect on remodeling, although no new
cardiac cell types (endothelial cells, fibroblasts, SMCs, or cardiomyocytes) could
be traced to human origin. The capacities, expressed within the normal embryonic
state, seem to be preserved in adult life and in disease states.
2.6 Future Directions and Clinical Applications
Many positive effects of EPDCs either after injection or by stimulation of the
dormant native epicardial covering of the heart are due to a paracrine mechanism
[22, 24, 25]. These findings bear important potential for drug and cell-based
therapeutic approaches to stimulate the native epicardium in repair of the ischemic
cardiac wall. An underdeveloped area is the priming of grafts taken from the
pericardium for use in cardiac or arterial repair.
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